Equities

Remedent Inc

REMI:PKC

Remedent Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.055
  • Today's Change0.00 / 0.00%
  • Shares traded1.00k
  • 1 Year change-67.65%
  • Beta-0.0826
Data delayed at least 15 minutes, as of Apr 12 2024 18:41 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.

  • Revenue in USD (TTM)1.13m
  • Net income in USD-259.38k
  • Incorporated1986
  • Employees16.00
  • Location
    Remedent IncBelgium Zuiderlaan 1-3 Bus 8GENT 9000BelgiumBEL
  • Phone+32 92415880
  • Fax+32 92415899
  • Websitehttps://www.remedent.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SPO Global Inc838.00k-540.00k583.05k2.00------0.6958-85.99-85.99131.76-476.561.76-------113.56-305.39----31.1527.31-64.44-384.85---1.45-----17.09-15.1313.03------
Sientra Inc90.30m-59.33m605.06k304.00------0.0067-5.45-5.438.10-2.820.59051.152.82297,036.20-38.80-45.08-163.51-76.2242.1155.37-65.71-103.790.3106-14.232.20--12.2319.90-17.26--14.01--
Nemaura Medical Inc0.00-10.65m866.98k36.00---------0.3787-0.37870.00-0.61690.000.00--0.00-117.49-58.18---131.96-------7,384.830.0305-1.4710.81---84.71---1.85--64.14--
SETO Holdings Inc4.96m-652.00k1.00m18.00--0.0911--0.2024-0.056-0.0560.39940.1341.572.658.51---20.703.84-29.075.9552.8352.44-13.153.920.99211.240.3040.0019.015.44-61.23------
Remedent Inc1.13m-259.38k1.10m16.00--0.2324--0.9743-0.013-0.0130.05650.23670.14743.452.69---3.247.35-5.2012.9365.3864.60-21.9721.200.2033-0.7720.00---33.63-21.70-140.31------
Hawkeye Systems Inc0.00-804.18k1.13m44.00---------0.1186-0.11860.00-0.290.00-------66.07-330.11-----------218.49---2.7810.45------4.85------
Invivo Therapeutics Holdings Corp0.00-9.33m1.15m6.00--0.1288-----3.53-3.530.002.870.00----0.00-81.32-73.69-94.35-85.63------------0.00-------6.01--19.74--
Kelyniam Global Inc517.70k-420.28k1.29m0.00--2.41--2.49-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Grapefruit USA Inc34.85k-4.37m1.33m9.00------38.11-0.008-0.0080.00006-0.01010.01211.310.22593,872.22-151.85-268.93-----1,304.65-10.09-12,531.68-408.870.0388-1.50-----83.9677.87-35.68------
Escalon Medical Corp12.38m450.50k1.48m38.007.721.582.990.11980.02590.02591.180.19512.654.048.01325,898.7014.68-1.7635.71-3.6746.2644.575.54-0.91141.0931.900.1504--13.801.33760.89-17.06-19.85--
Tivic Health Systems Inc1.23m-8.26m1.54m16.00--0.267--1.25-42.45-42.452.753.930.16131.0710.8676,687.50-108.51---135.42--26.49---672.78--5.53--0.00--46.38---18.86------
Bone Biologics Corp0.00-8.95m1.61m2.00--0.3364-----77.05-77.050.005.440.00----0.00-146.30-98.31-202.15--------------0.00-------502.76------
Data as of Apr 12 2024. Currency figures normalised to Remedent Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.